Cited 66 times in
The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강숙희 | - |
dc.contributor.author | 김백길 | - |
dc.contributor.author | 장연수 | - |
dc.contributor.author | 조남훈 | - |
dc.date.accessioned | 2020-02-11T06:53:47Z | - |
dc.date.available | 2020-02-11T06:53:47Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/174891 | - |
dc.description.abstract | Stroma-derived exosomal microRNA (exomiR) contributes to tumor progression, however, which remains poorly understood. In our study, we analyzed exomiRs from the cancer-associated fibroblast (CAF) and normal fibroblast (NF) isolated from an invasive ductal carcinoma (IDC) patient and found that the level of microRNA (miR)-4516 was approximately 5-fold lower in CAF-derived exosomes than NF-derived ones. In gene annotation analysis, miR-4516 target genes were mainly associated with the regulation of proliferation. miR-4516 overexpression or mimic treatment suppressed the proliferation of breast cancer cells, especially triple negative breast cancer (TNBC) cells. Among miR-4516 targets, FOSL1 was overexpressed in TNBC cells compared to non-TNBC cells and promoted tumor proliferation. The expression of miR-4516 and FOSL1 was reversely correlated in breast cancer patient tissues. Particularly, TNBC patients with high FOSL1 expression showed a significant poorer survival than those with low FOSL1 expression. Our results show that the loss of miR-4516 from CAF-derived exosomes is associated with FOSL1-dependent TNBC progression and suggest that miR-4516 can be used as an anti-cancer drug for TNBC. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier Science Ireland | - |
dc.relation.isPartOf | CANCER LETTERS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학교실) | - |
dc.contributor.googleauthor | Ji Eun Kim | - |
dc.contributor.googleauthor | Baek Gil Kim | - |
dc.contributor.googleauthor | Yeonsue Jang | - |
dc.contributor.googleauthor | Suki Kang | - |
dc.contributor.googleauthor | Joo Hyun Lee | - |
dc.contributor.googleauthor | Nam Hoon Cho | - |
dc.identifier.doi | 10.1016/j.canlet.2019.10.039 | - |
dc.contributor.localId | A00044 | - |
dc.contributor.localId | A00484 | - |
dc.contributor.localId | A03449 | - |
dc.contributor.localId | A03812 | - |
dc.relation.journalcode | J00448 | - |
dc.identifier.eissn | 1872-7980 | - |
dc.identifier.pmid | 31672492 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0304383519305427 | - |
dc.subject.keyword | CAF | - |
dc.subject.keyword | Exosome | - |
dc.subject.keyword | FOSL1 | - |
dc.subject.keyword | Triple negative breast cancer | - |
dc.subject.keyword | miR-4516 | - |
dc.contributor.alternativeName | Kang, Suki | - |
dc.contributor.affiliatedAuthor | 강숙희 | - |
dc.contributor.affiliatedAuthor | 김백길 | - |
dc.contributor.affiliatedAuthor | 장연수 | - |
dc.contributor.affiliatedAuthor | 조남훈 | - |
dc.citation.volume | 469 | - |
dc.citation.startPage | 256 | - |
dc.citation.endPage | 265 | - |
dc.identifier.bibliographicCitation | CANCER LETTERS, Vol.469 : 256-265, 2020 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.